Literature DB >> 24080799

Chronic kidney disease: optimal blood pressure for kidney disease-lower is not better.

George Bakris1.   

Abstract

Current guidelines recommend lowering blood pressure (BP) in patients with chronic kidney disease and hypertension. However, a new study suggests that achieving ideal systolic BP targets at the expense of low diastolic BP <70 mmHg is not advantageous for outcomes.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24080799     DOI： 10.1038/nrneph.2013.206

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


  10 in total

Review 1.  The j-point phenomenon in aggressive therapy of hypertension: new insights.

Authors:  Gurusher S Panjrath; Sameer Chaudhari; Franz H Messerli
Journal:  Curr Atheroscler Rep       Date:  2012-04       Impact factor: 5.113

2.  Blood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort study.

Authors:  Csaba P Kovesdy; Anthony J Bleyer; Miklos Z Molnar; Jennie Z Ma; John J Sim; William C Cushman; L Darryl Quarles; Kamyar Kalantar-Zadeh
Journal:  Ann Intern Med       Date:  2013-08-20       Impact factor: 25.391

3.  Intensive blood-pressure control in hypertensive chronic kidney disease.

Authors:  Lawrence J Appel; Jackson T Wright; Tom Greene; Lawrence Y Agodoa; Brad C Astor; George L Bakris; William H Cleveland; Jeanne Charleston; Gabriel Contreras; Marquetta L Faulkner; Francis B Gabbai; Jennifer J Gassman; Lee A Hebert; Kenneth A Jamerson; Joel D Kopple; John W Kusek; James P Lash; Janice P Lea; Julia B Lewis; Michael S Lipkowitz; Shaul G Massry; Edgar R Miller; Keith Norris; Robert A Phillips; Velvie A Pogue; Otelio S Randall; Stephen G Rostand; Miroslaw J Smogorzewski; Robert D Toto; Xuelei Wang
Journal:  N Engl J Med       Date:  2010-09-02       Impact factor: 91.245

4.  Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial.

Authors:  Piero Ruggenenti; Annalisa Perna; Giacomina Loriga; Maria Ganeva; Bogdan Ene-Iordache; Marta Turturro; Maria Lesti; Elena Perticucci; Ivan Nediyalkov Chakarski; Daniela Leonardis; Giovanni Garini; Adalberto Sessa; Carlo Basile; Mirella Alpa; Renzo Scanziani; Gianbattista Sorba; Carmine Zoccali; Giuseppe Remuzzi
Journal:  Lancet       Date:  2005 Mar 12-18       Impact factor: 79.321

5.  Blood pressure components and end-stage renal disease in persons with chronic kidney disease: the Kidney Early Evaluation Program (KEEP).

Authors:  Carmen A Peralta; Keith C Norris; Suying Li; Tara I Chang; Manjula K Tamura; Stacey E Jolly; George Bakris; Peter A McCullough; Michael Shlipak
Journal:  Arch Intern Med       Date:  2012-01-09

Review 6.  Summary of KDIGO guideline. What do we really know about management of blood pressure in patients with chronic kidney disease?

Authors:  David C Wheeler; Gavin J Becker
Journal:  Kidney Int       Date:  2013-01-16       Impact factor: 10.612

7.  Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study.

Authors:  J C Peterson; S Adler; J M Burkart; T Greene; L A Hebert; L G Hunsicker; A J King; S Klahr; S G Massry; J L Seifter
Journal:  Ann Intern Med       Date:  1995-11-15       Impact factor: 25.391

8.  2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redón; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad
Journal:  J Hypertens       Date:  2013-07       Impact factor: 4.844

9.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

Authors:  L Hansson; A Zanchetti; S G Carruthers; B Dahlöf; D Elmfeldt; S Julius; J Ménard; K H Rahn; H Wedel; S Westerling
Journal:  Lancet       Date:  1998-06-13       Impact factor: 79.321

10.  Summary of revisions for the 2013 clinical practice recommendations.

Authors: 
Journal:  Diabetes Care       Date:  2013-01       Impact factor: 19.112
  10 in total
  2 in total

Review 1.  Update on blood pressure goals in diabetes mellitus.

Authors:  Luke J Laffin; George L Bakris
Journal:  Curr Cardiol Rep       Date:  2015-06       Impact factor: 2.931

2.  Loss of nighttime blood pressure dipping as a risk factor for coronary artery calcification in nondialysis chronic kidney disease.

Authors:  Hoon Young Choi; Chan Joo Lee; Jung Eun Lee; Hyun Su Yang; Ha Yan Kim; Hyeong Cheon Park; Hyeon Chang Kim; Hyuk-Jae Chang; Sung-Ha Park; Beom Seok Kim
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.